4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-14-000047
Options or other derivatives
- President & CEO acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SCHWARTZ MARK W. President & CEO | 2014-09-16 | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…